Novartis buys Endocyte for $2.1 billion

18th October 2018 Uncategorised 0

Novartis has signed a deal to acquire US biopharma Endocyte, securing itself access to novel radiopharmaceutical programmes “with significant sales potential”.

More: Novartis buys Endocyte for .1 billion
Source: News